This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
ELISA/assay
product name :
FOUR-COLOR HUMAN CD45RA/CD45RO/CD8/CD3 FLOW KIT
catalog :
4C005
quantity :
50 TESTS/0.5 ml
product information
Entity Category :
Antibodies
Product Code :
4C005
Description :
FOUR-COLOR HUMAN CD45RA/CD45RO/CD8/CD3 FLOW KIT
Specificity :
CD45RA/CD45RO/CD8/CD3
Target Species :
Human
Host :
Multiple
Format :
4 Color
Isotypes :
Cocktail
Applications :
F
Application Types :
Flow Cytometry
Clone :
F8-11-13 / UCHL1 / LT8 / UCHT1
Quantity :
50 TESTS/0.5ml
Quantity Value :
50 TESTS/0.5 ml
Quantity Type :
TESTS/0.5ml
GO Accessions :
GO:0001915, GO:0001960, GO:0002378, GO:0005001, GO:0005887, GO:0005925, GO:0006469, GO:0006470, GO:0007411, GO:0019901, GO:0030890, GO:0033261, GO:0042100, GO:0045121, GO:0050852, GO:0050853, GO:0050857, GO:0051209, GO:0051607, GO:0004888, GO:0005057, GO:0005887, GO:0007172, GO:0007186, GO:0009897, GO:0017124, GO:0019901, GO:0030159, GO:0031295, GO:0042608, GO:0046982, GO:0050852, GO:0005576, GO:0007169, GO:0005887, GO:0015026, GO:0019882, GO:0042101, GO:0042288, GO:0050776
GO Terms :
activation of antigen receptor-mediated signaling pathway, activation of B cell proliferation, alpha-beta T cell receptor activity, antibody biosynthesis, antibody biosynthetic process, antigen presentation, antigen processing, antiviral response, axon chemotaxis, axon growth cone guidance, axon pathfinding, B cell receptor signalling pathway, B lymphocyte proliferation, B lymphocyte receptor signaling pathway, B lymphocyte receptor signalling pathway, B-cell proliferation, B-cell receptor signaling pathway, B-cell receptor signalling pathway, B-lymphocyte proliferation, B-lymphocyte receptor signaling pathway, B-lymphocyte receptor signalling pathway, calcium ion (Ca2+) mobilization, calcium mobilization, coreceptor, insoluble ligand activity, coreceptor, soluble ligand activity, cytoplasmic release of sequestered calcium ion (Ca2+), cytoplasmic release of stored calcium ion (Ca2+), cytosolic release of sequestered calcium ion (Ca2+), cytosolic release of stored calcium ion (Ca2+), defence response to virus, defense response to viruses, down regulation of cytokine mediated signaling pathway, down regulation of protein kinase activity, down regulation of T cell mediated cytotoxicity, downregulation of cytokine mediated signaling pathway, down-regulation of cytokine mediated signaling pathway, downregulation of protein kinase activity, down-regulation of protein kinase activity, downregulation of T cell mediated cytotoxicity, down-regulation of T cell mediated cytotoxicity, extracellular, focal contact, G protein coupled receptor protein signaling pathway, G protein coupled receptor protein signalling pathway, gamma-delta T cell receptor activity, GEM domain, glycolipid-enriched membrane domain, GO:0004926, GO:0008040, GO:0008357, GO:0015027, GO:0015028, GO:0030333, GO:0042114, GPCR protein signaling pathway, GPCR protein signalling pathway, G-protein coupled receptor protein signal transduction, G-protein coupled receptor protein signalling pathway, G-protein-coupled receptor protein signaling pathway, G-protein-coupled receptor protein signalling pathway, hemi-adherens junction, inhibition of cytokine mediated signaling pathway, inhibition of protein kinase activity, inhibition of T cell mediated cytotoxicity, juxtamembrane, lipid raft, major histocompatibility complex class I binding, major histocompatibility complex class I ligand, negative regulation of cytokine and chemokine mediated signaling pathway, negative regulation of cytokine mediated signaling pathway, negative regulation of cytokine mediated signalling pathway, negative regulation of T cell mediated apoptosis, negative regulation of T cell mediated cell death, negative regulation of T cell mediated cell killing, negative regulation of T cell mediated cytolysis, negative regulation of T lymphocyte mediated cytotoxicity, negative regulation of T-cell mediated apoptosis, negative regulation of T-cell mediated cell death, negative regulation of T-cell mediated cell killing, negative regulation of T-cell mediated cytolysis, negative regulation of T-cell mediated cytotoxicity, negative regulation of T-lymphocyte mediated cytotoxicity, non G protein coupled 7TM receptor activity, non-G-protein coupled 7TM receptor activity, non-G-protein-coupled 7TM receptor activity, outer surface of cytoplasmic membrane, positive regulation of antigen receptor mediated signalling pathway, positive regulation of B lymphocyte proliferation, positive regulation of B-cell proliferation, positive regulation of B-lymphocyte proliferation, protein amino acid dephosphorylation, receptor signaling complex scaffold protein activity, receptor signalling complex scaffold activity, receptor signalling protein activity, regulation of progression through S phase, regulation of S-phase, release of sequestered calcium ion (Ca2+), release of sequestered calcium ion into cytoplasm, release of stored calcium ion (Ca2+), release of stored calcium ion (Ca2+) into cytoplasm, release of stored calcium ion (Ca2+) into cytosol, signal complex formation, stimulation of antigen receptor-mediated signaling pathway, stimulation of B cell proliferation, T cell co-stimulation, T cell receptor activity, T lymphocyte costimulation, T lymphocyte receptor binding, T lymphocyte receptor complex, T lymphocyte receptor signaling pathway, T lymphocyte receptor signalling pathway, T-cell costimulation, T-cell co-stimulation, T-cell receptor binding, T-cell receptor complex, T-cell receptor signaling pathway, T-cell receptor signalling pathway, TCR, TCR binding, TCR signaling pathway, T-lymphocyte costimulation, T-lymphocyte receptor binding, T-lymphocyte receptor complex, T-lymphocyte receptor signaling pathway, T-lymphocyte receptor signalling pathway, transmembrane receptor protein tyrosine kinase signalling pathway, up regulation of antigen receptor-mediated signaling pathway, up regulation of B cell proliferation, up-regulation of antigen receptor-mediated signaling pathway, upregulation of antigen receptor-mediated signaling pathway, upregulation of B cell proliferation, up-regulation of B cell proliferation
Uniprot Accessions :
P01732, P07766, P08575
Gene :
CD3E, CD8A, PTPRC
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5788, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=916, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=925
EntityFormats :
4 Color
UNSPSC :
41116161
Product Form :
Four color combination consisting of FITC, RPE, APC and RPE-Cy5.5 conjugated monoclonal antibodies mixed in optimal ratio - lyophilised. FITC conjugated CD45RA (Mouse IgG1) RPE conjugated CD45RO (Mouse IgG2a) APC conjugated CD8 (Mouse IgG1) RPE-Cy5.5 conjugated CD3 (Mouse IgG1)
PrimarySecondary :
Primary
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.